Location: Home
  • search
  • go
  • Relate News
  • 1/3/2022Daewoong Submits BTX Product Nabota in China
  • 1/3/2022Hanmi Pharma Out-licenses Retinal Disease Drug to China's AffaMed
  • 1/3/2022Third Former GSK Scientist Pleads Guilty to Stealing Trade Secrets to ...
  • 12/31/2021CDE Issues Clarification for Implementation of ICH M9
  • 12/31/2021Long Winter Sets In for Both MNCs and Domestic Champions as 2021 NRDL ...
  • 12/30/2021Sirnaomics Launches IPO on the Main Board of Stock Exchange of Hong K...
  • 12/30/2021Ark Biopharma Enters Into License Deal with Commave for ADHD Drug Azst...
  • 12/30/2021Ant Group to Shut Down China's Largest Crowdfunded Healthcare Mutual ...
  • 12/30/2021NMPA and Chinese Customs Announce Addition of Zhongshan City's Zhongsh...
  • 12/30/2021CDE Issues the Guiding Principles for Comprehensive Efficacy Analysis ...
  • 12/30/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (54...
  • 12/30/2021NMPA Issues the 14th Five Year Plan for National Drug Safety and Promo...
  • 12/30/2021Drug R&D and Product Registration News Digest December 2021 (2)
  • 12/30/2021Financial-related Company News Digest (December 2021)
  • 12/30/2021Recent Executive Moves
  • 12/29/2021Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discu...
  • 12/29/2021CDE Issues the Guidelines for Clinical Research of Late Term Colorecta...
  • 12/29/2021CDE Issues the Technical Guidelines for Expansion Cohorts in First-In-...
  • 12/29/2021CDE Issues the Technical Guidelines for Clinical Single- And Multiple-...
  • 12/29/202118 Promising Novel Drugs Expected to Be Approved in China 2022
  • 12/29/2021Top Ten Chinese Biopharma In-licensing Deals in 2021
  • 12/29/2021Data Review – Chinese Oncology New Drug R&D Landscape
  • 12/29/2021China-Only Studies Are ‘Problematic,’ US FDA’s Pazdur Says Ahead of...
  • 12/28/2021NHC Issues the Guidelines for Clinical Application of New Anticancer D...
  • 12/28/2021SMEI Forecasts Outlook of Chinese Pharma in 2022
  • 12/27/2021China Issues Five Year Plan on Occupational Disease Prevention and Tre...
  • 12/27/2021NMPA Announces Rx Switch of OTC Dextromethorphan Hydrobromide Oral Sin...
  • 12/27/2021China Revises the Law on Progress of Science and Technology to Emphasi...
  • 12/27/2021ITM and Grand Pharma Enter Licensing Deal for Targeted Radiopharmaceut...
  • 12/27/2021Kintor Reports Unsatisfactory Interim Analysis on COVID-19 Pill Trial
  • Page:154/774 Total number of articles:23207: [First][<<] [152] [153] [154] [155] [156] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group